NM_000251.3:c.2038C>T
Variant summary
The NM_000251.3(MSH2):c.2038C>T (p.Arg680*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant is predicted to lead to nonsense-mediated mRNA decay (NMD). The variant allele was found at a cumulative frequency of 0.00000137 (AC=2) in the gnomAD database across 1,461,874 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.000000899. In-silico predictor (BayesDel (noAF)) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★★). ClinVar reports functional evidence for this variant: "SCV004699464: PS3:Supporting". This exact variant is curated in the UniProt human variants database as Uncertain Significance; it is also listed as a COSMIC curated somatic variant.
Frequency
Consequence
NM_000251.3 stop_gained
Scores
Clinical Significance
Conservation
Publications
- Lynch syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, G2P, Orphanet
- Lynch syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
- mismatch repair cancer syndrome 1Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- mismatch repair cancer syndrome 2Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- Muir-Torre syndromeInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- ovarian cancerInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- malignant pancreatic neoplasmInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- prostate cancerInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- rhabdomyosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- breast cancerInheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
Classification according to ACMG Germline Pathogenicity v2019
Our verdict: Pathogenic. The variant received 22 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| PVS1Null variant in LOF gene | Frameshift/stop-gained, NMD predicted, LoF disease mechanism — very strong (PVS1); Stop-gained (exon 13 of 16) at amino acid 680 of 934, predicted to trigger nonsense-mediated mRNA decay. Loss of function is a known disease mechanism for this gene. | ||
| PS3Functional studies show damaging effect | Well-established functional study supports damaging effect (PS3); SCV004699464: PS3:Supporting | ||
| PM2Absent/extremely low in population databases | Very rare in gnomAD for AD/XL gene (popmax AF < threshold/10) — PM2; GnomAD popmax AF = 0.000000899 — very rare for AD+AR gene (base 0.0001, raised to 0.0005 by highest known P/LP ClinVar AF 0.00268) — PM2 moderate. | ||
| PP5Reputable source reports pathogenic | ClinVar ≥3 stars pathogenic — very strong (PP5); ClinVar submissions overwhelmingly pathogenic (≥10 total, ≥80% P/LP, <10% B/LB) — strong (PP5, count-based); ClinVar germline classification: Pathogenic/Likely Pathogenic, 3 star(s). ClinVar submissions strongly and reliably favor pathogenicity (24/25 total P/LP). |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_000251.3. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
MSH2 | MANE Select | c.2038C>T p.Arg680* | stop_gained | Exon 13 of 16 | Prot: NP_000242.1 UniProt: | |
MSH2 | c.2038C>T p.Arg680* | stop_gained | Exon 13 of 18 | Prot: NP_001393603.1 | ||
MSH2 | c.2038C>T p.Arg680* | stop_gained | Exon 13 of 18 | Prot: NP_001393560.1 |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
MSH2 | TSL:1MANE Select | c.2038C>T p.Arg680* | stop_gained | Exon 13 of 16 | Prot: ENSP00000233146.2 UniProt: | |
MSH2 | TSL:1 | c.2038C>T p.Arg680* | stop_gained | Exon 13 of 16 | Prot: ENSP00000384199.1 UniProt: | |
MSH2 | c.2089C>T p.Arg697* | stop_gained | Exon 14 of 17 | Prot: ENSP00000588166.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 6 sources | |||||
GnomAD3 genomes | Cov:32 | ||||
GnomAD2 exomes | AF: 0.00000398 | AC:1 | AN:251446 | ||
GnomAD4 exome | AF: 0.00000137 | AC:2 | Hom:0 | AN:1461874 | Cov:32 |
GnomAD4 genome | Cov:32 | ||||
TOPMed (Bravo) | AF: 0.00000378 | AC:1 | Hom:0 | AN:264690 | |
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.00 | AC:0 | Hom:0 | AN:217698 | |
Case/control cohorts
| Cohort | Cases | Controls | ||||
|---|---|---|---|---|---|---|
| AF | AC | AN | AF | AC | AN | |
BipEx | 0.0000352 | 1 | 28420 | 0.00 | 0 | 28844 |
Epi25 | 0.0000238 | 1 | 41958 | 0.00 | 0 | 66888 |
SCHEMA | 0.00 | 0 | 67520 | 0.00000754 | 1 | 132634 |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 40 | |
BayesDel_addAF | Pathogenic | 0.63 | D |
BayesDel_noAF | Pathogenic | 0.66 | |
CADD | Pathogenic | 54 | |
DANN | Uncertain | 1.0 | |
Eigen | Pathogenic | 0.95 | |
Eigen_PC | Pathogenic | 0.85 | |
FATHMM_MKL | Pathogenic | 0.98 | D |
GPN-Star LLR | N/A | -10 | |
GPN-Star score | N/A | 10 | |
Mutation Taster | N/A | 0/200 | disease causing (ClinVar) |
PhyloP100 | Uncertain | 5.7 | |
RBP_binding_hub_radar | N/A | 0.0 | |
RBP_regulation_power_radar | N/A | 1.7 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.15 | |
Pangolin loss | Benign | 0.15 | Position offset: -32 |
SpliceAI score (max) | Benign | 0.030 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.